Revascularization for left main and multivessel coronary artery disease in the drug-eluting stent era: integration of recent drug-eluting stent trials.
As older patients comprise a greater proportion of the population, the incidence of multivessel and left main coronary artery disease is increasing. Given the improvements in percutaneous coronary intervention, more patients are suitable for this revascularization strategy. However, the optimal revascularization strategy remains a moving target. Numerous trials, extending from the bypass surgery versus medical therapy era to the most current drug-eluting stent versus bypass surgery era, provide information to select the most appropriate revascularization strategy. The objective of this review is to summarize these data.
Brigham and Women's Hospital, Boston, MA, USA. svasaiwala@partners.org
Samip
S
Vasaiwala
David O
DO
Williams
D015906:Angioplasty, Balloon, Coronary; D018849:Controlled Clinical Trials as Topic / Q000379:methods; D001026:Coronary Artery Bypass; D003324:Coronary Artery Disease / Q000473:pathology / Q000628:therapy*; D054855:Drug-Eluting Stents; D006801:Humans; D009204:Myocardial Revascularization / Q000379:methods*